Single-use System– tag –
-
Reusable Bioreactor Market Surges: Driven by Large-Volume Biologics Production and CDMO Capacity Expansion, Hybrid Manufacturing Emerges
Constancy Researchers USA Overview The reusable bioreactor market is experiencing substantial growth, propelled by the increasing demand for large-volume commercial biopharmaceutical production and the expansion of CDMO capacities. A not... -
Perfusion Bioreactor Market Surges Driven by Continuous Biomanufacturing and Intensified Bioprocessing; Thermo Fisher’s DynaDrive Platform Leads
Constancy Researchers USA Overview The perfusion bioreactor market is experiencing rapid growth, primarily fueled by the adoption of continuous biomanufacturing and intensified bioprocessing strategies. Thermo Fisher Scientific's HyPerfo... -
Thermo Fisher Unveils DynaDrive 5L Single-Use Bioreactor, Enabling Seamless 1L to 5,000L Scale-Up for Biologics Manufacturing
Constancy Researchers USA Overview Thermo Fisher Scientific has launched its DynaDrive 5L single-use bioreactor, designed to enhance workflow efficiency in biopharmaceutical manufacturing. This new system facilitates seamless culture sca... -
Kincell Bio Inaugurates and Expands State-of-the-Art GMP Cell Therapy Manufacturing Facilities in Gainesville and Research Triangle Park
Kincell Bio USA Overview Kincell Bio has opened and expanded GMP cell therapy manufacturing facilities in Gainesville, Florida, and Research Triangle Park, North Carolina, designed to support both autologous and allogeneic cell therapies... -
Continuous Bioprocessing Delivers Significant Gains in Biopharmaceutical Manufacturing Efficiency and Cost Reduction, Driven by 500L Single-Use Perfusion Bioreactors
BioProcess International USA Overview Biopharmaceutical manufacturers are rapidly adopting continuous bioprocessing, integrating upstream cell culture and downstream operations to boost productivity, cut costs, and reduce facility footpr... -
Sartorius Accelerates Cell & Gene Therapy Commercialization with Comprehensive End-to-End Solutions
Sartorius Germany Overview Sartorius emphasizes its mission to accelerate the commercialization of cell and gene therapies (CGT) by providing end-to-end solutions that deliver reproducible performance and scalability. Its portfolio suppo... -
APAC’s Bioprocessing Technology Ready, Regulatory Certainty Needed for Continuous Manufacturing Investment; China/Korea CDMOs Lead Adoption
BioProcess International USA Overview A BioProcess International article analyzes regulatory challenges for continuous and intensified bioprocessing adoption in the Asia Pacific (APAC) region. While hardware and software for perfusion bi... -
Market Report: Global Single-Use Bioreactor Market to Surge, Thermo Fisher and AGC Biologics Expand Capacity
GlobeNewswire Global Overview This article summarizes the market research report "Global Single-use Bioreactors Market Forecast to Surge from USD 3.61 Billion in 2025 to USD 15.11 Billion by 2034." The global single-use bioreactors marke... -
Biologics Outsourcing Redefined: Modality Expertise & End-to-End Integration Key for Partnerships
Bioprocess Online USA Overview Biologics manufacturing outsourcing is evolving into strategic partnerships focused on modality expertise, regulatory excellence, and end-to-end integration, moving beyond mere cost savings. To support incr... -
In-Line Sensors Play Crucial Role in Single-Use Biomanufacturing, Driving PAT Adoption and Enhancing Process Control
Technology Networks Global Overview In-line sensors are proving indispensable in single-use biomanufacturing for improving process efficiency and reliability. Directly integrated into single-use bioreactor bags, these sensors enable cont...
